Monday AM 1 Opening Session 2011 Mansfield Lecture ... - ISMRM

Thursday PM
17:36 649. Prospective Motion Correction for Diffusion Imaging using FID Navigators
Tobias Kober 1,2 , Rolf Gruetter 1,3 , Gunnar Krueger 2
1 Laboratory for functional & metabolic imaging, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; 2 Advanced
Clinical Imaging Technology, Siemens Suisse SA - CIBM, Lausanne, Switzerland; 3 Departments of Radiology, Universities of
Lausanne & Geneva, Switzerland
17:48 650. A Robust MR-Based Rigid-Body Motion Correction for Simultaneous MR-PET
Marcus Goerge Ullisch 1 , Christoph Weirich 1 , Juergen Scheins 1 , Elena Rota Kops 1 , Avdo Celik 1 , Tony Stöcker 1 , Nadim
Jon Shah 1,2
1 Institute of Neuroscience and Medicine - 4, Forschungszentrum Juelich, Juelich, Germany; 2 Department of Neurology, Faculty of
Medicine, JARA, RWTH Aachen University, Aachen, Germany
Hyperpolarized 13 C
Room 518-A-C 16:00-18:00 Moderators: Dirk Mayer & Rahim R. Rizi
16:00 651. Hyperpolarized 13 C MR Metabolic Imaging Provides an Early Biomarker of MGMT Activity & Response to
Temozolomide Treatment
Ilwoo Park 1 , Llewellyn E. Jalbert 1 , Tomoko Ozawa 2 , C. David James 2 , Joanna J. Phillips 2 , Daniel B. Vigneron 1,3 ,
Russell O. Pieper 2 , Sabrina M. Ronen 1 , Sarah J. Nelson 1,3
1 Surbeck Laboratory of Advanced Imaging, Department of Radiology & Biomedical Imaging, University of California, San Francisco,
San Francisco, CA, USA; 2 Brain Tumor Research Center, Department of Neurological Surgery, University of California, San
Francisco, San Francisco, CA, USA; 3 Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco,
San Francisco, CA, USA
16:12 652. Hyperpolarized 13 C magnetic Resonance Spectroscopy Detects Early Changes in Tumor Metabolism Following
Treatment with the Anti-Angiogenic Agent Bevacizumab
Sarah E. Bohndiek 1,2 , De-en Hu 1,2 , Mikko I. Kettunen 1,2 , Kevin M. Brindle 1,2
1 Department of Biochemistry, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom; 2 Cambridge Research
Institute, Cancer Research UK, Cambridge, Cambridgeshire, United Kingdom
16:24 653. Monitoring Metabolic Shifts in TRAMP Mice Resulting from Dichloroacetate using Hyperpolarized Pyruvate
Aaron Keith Grant 1 , Pankaj K. Seth 2 , Elena Vinogradov 1 , Xiaoen Wang 1 , Vikas P. Sukhatme 2 , Robert E. Lenkinski 1
1 Radiology, Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA, USA; 2 Medicine, Beth Israel Deaconess
Medical Center & Harvard Medical School, Boston, MA, USA
16:36 654. Exchange-Linked Dissolution Agents in 13 C Metabolic Imaging
Ralph E. Hurd 1 , Daniel Spielman 2 , Sonal Josan 3 , Yi-Fen Yen 1 , Adolf Pfefferbaum 3,4 , Dirk Mayer 2,3
1 GE Healthcare, Menlo Park, CA, USA; 2 Department of Radiology, Stanford University, Stanford, CA, USA; 3 Neuroscience Program,
SRI International, Menlo Park, CA, USA; 4 Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA
16:48 655. Hyperpolarized C-13 Metabolic Activity Decomposition with Stimulated-echoes
Peder Eric Zufall Larson 1 , Adam B. Kerr 2 , John M. Pauly 2 , Daniel B. Vigneron 1
1 2
Radiology & Biomedical Imaging, UC - San Francisco, San Francisco, CA, USA; Electrical Engineering, Stanford University,
Stanford, CA, USA
17:00 656. T 1 Nuclear Magnetic Resonance Dispersion of Hyperpolarized [1- 13 C] Pyruvate
Francisco M. Martinez-Santiesteban 1 , Lanette Friesen Waldner 2 , Timothy James Scholl 1,2
1 Department of Medical Biophysics, University of Western Ontario, London, ON, Canada; 2 Imaging Research Laboratories, Robarts
Research Institute, University of Western Ontario, London, ON, Canada
17:12 657. Simultaneous Investigation of Cardiac Pyruvate Dehydrogenase Flux, Krebs Cycle Metabolism & Intracellular
Ph using Hyperpolarized [1,2- 13 C 2] Pyruvate
Albert P. Chen 1 , Ralph E. Hurd 2 , Marie A. Schroeder 3,4 , Angus Z. Lau 4,5 , Yi-Ping Gu 4 , Wilfred W. Lam 4 , Jennifer
Barry 4 , James Tropp 6 , Charles H. Cunningham 4,5
1 GE Healthcare, Toronto, ON, Canada; 2 GE Healthcare, Menlo Park, CA, USA; 3 Department of Physiology, Anatomy & Genetics,
University of Oxford, Oxford, United Kingdom; 4 Imaging Research, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;
5 Deptartment of Medical Biophysics, University of Toronto, Toronto, ON, Canada; 6 GE Healthcare, Fremont, CA, USA
17:24 658. Hyperpolarized Butyrate: A Novel Substrate for the Assessment of Cardiac Fatty Acid Metabolism
Daniel Ball 1 , Michael Dodd 1 , Helen Atherton 2 , Marie Schroeder 1 , Carolyn Carr 1 , George Radda 1 , Kieran Clarke 1 ,
Damian Tyler 1
1 Department of Physiology, Anatomy & Genetics, Oxford University, Oxford, Oxfordshire, United Kingdom; 2 Department of
Biochemistry, Cambridge University
91